Shi-MingTuMD
Oncology • Little Rock, ARProfessor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Dr. Tu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UAMS Medical Center
449 Jack Stephens Drive Winthrop P. Rockefeller Cancer Institute, Seventh Floor
Little Rock, AR 72205Phone+1 501-686-8530
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1990 - 1993
University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 1989 - 1990- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1987 - 1990
- University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 1987 - 1988
Washington University in St. Louis School of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 1992 - Present
FL State Medical License 2021 - Present
AR State Medical License 2021 - 2025
TX State Medical License 1993 - 2024
OK State Medical License 2020 - 2021- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer Start of enrollment: 2002 Apr 01
- Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases Start of enrollment: 2002 Feb 01
- Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases Start of enrollment: 2004 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Doxorubicin, Paclitaxel, and Cisplatin (ATP) for Relapsed/Refractory Germ Cell Tumors.Jenny J Xiang, Matthew T Campbell, Shi-Ming Tu, John Araujo, Yago Nieto
Clinical Genitourinary Cancer. 2024-12-01 - Epithelioid trophoblastic tumor in male patients with germ cell tumor: A clinicopathologic analysis of five cases.Georges C Tabet, Lan Zheng, Hossein Hosseini, John Ward, Louis Pisters
Human Pathology. 2024-11-01 - 1 citationsGerm Cell Tumor of the Testis: Lethal Subtypes of a Curable Cancer.Jamaal C Jackson, Darren Sanchez, Andrew C Johns, Matthew T Campbell, Ahmet M Aydin
Journal of Clinical Medicine. 2024-06-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
